http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-8304-M

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D11-0492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-23
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
filingDate 1968-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1970-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1970-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-8304-M
abstract 1,219,316. Thyrocalcitonin extraction. MERCK & CO Inc. 8 July, 1968 [14 July, 1967], No. 32477/68. Heading A5B. The hypocalcemic peptide thyrocalcitonin is obtained in a pure state from a thyroid gland extract by the process comprising countercurrent extraction with a two phase, five component solvent system consisting essentially of pyridine, n-butanol, acetic acid, ammonium acetate and water in the proportions of 60-100 ml. of pyridine, 100 ml. of n-butanol, 1.2 to 5 ml. of acetic acid, 100 to 300 ml. of water, and 1 to 5 grams of ammonium acetate. The product of the extraction process may be further purified by countercurrent extraction with a two phase, three component n-butanolwater-acetic acid system, alternatively, the procedure may be reversed. The 3-component system may also be used before and after treatment with the 5-component system. The product may be further purified by conventional chromatographic or gel filtration methods. The preferred starting material is porcine thyroid glands and in particular a crude extract of the defatted gland obtained by extraction with a solvent system similar or the same as that used for the countercurrent extraction process. Reference is also made to pharmaceutical compositions containing as the active ingredient the product of the process of the invention.
priorityDate 1967-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01260
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID514876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453148806
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID796
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01257
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB5UBG1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID436744
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34181
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22056973
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403946
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA6P7L6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01261
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PM04
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01262
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9N0V5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450852399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12432
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01259

Total number of triples: 43.